These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6409465)

  • 21. Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.
    Gerich JE; Lorenzi M; Bier DM; Schneider V; Tsalikian E; Karam JH; Forsham PH
    N Engl J Med; 1975 May; 292(19):985-9. PubMed ID: 804137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts of the pathogenesis and management of diabetic ketoacidosis (DKA).
    Yan P; Cheah JS; Thai AC; Yeo PP
    Ann Acad Med Singap; 1983 Oct; 12(4):596-605. PubMed ID: 6331271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of somatostatin to correct manifest diabetic ketoacidosis.
    Lundbaek K; Hansen AP; Orskov H; Christensen SE; Iversen J; Seyer-Hansen K; Alberti KG; Whitefoot R
    Lancet; 1976 Jan; 1(7953):215-8. PubMed ID: 55530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans.
    Keller U; Gerber PP; Stauffacher W
    Am J Physiol; 1984 Dec; 247(6 Pt 1):E732-9. PubMed ID: 6150642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical characterization of ketosis-resistant young diabetics of northern India. In vivo effects of i.v. glucose, s.c. epinephrine and i.v. glucagon and in vitro effects of anti-insulin serum on adipose tissue lipolysis.
    Krishna Ram B; Sachdev G; Chopra A; Karmarkar MG
    Acta Diabetol Lat; 1984; 21(2):141-51. PubMed ID: 6433609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental hyperosmolar diabetic syndrome. Ketogenic response to medium-chain triglycerides.
    Gordon EE; Duga J
    Diabetes; 1975 Mar; 24(3):301-6. PubMed ID: 123210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus.
    MacGillivray MH; Voorhess ML; Putnam TI; Li PK; Schaefer PA; Bruck E
    Diabetes Care; 1982; 5 Suppl 1():38-47. PubMed ID: 6821306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of diabetic ketoacidosis. I. Insulin in the treatment of diabetic ketoacidosis].
    Fin'do B; Duhan L
    Vnitr Lek; 1974 Sep; 20(8):746-51. PubMed ID: 4211721
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute reversal of experimental diabetic ketoacidosis in the rat with (+)-decanoylcarnitine.
    McGarry JD; Foster DW
    J Clin Invest; 1973 Apr; 52(4):877-84. PubMed ID: 4632691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulation of ketogenesis.
    Foster DW; McGarry JD
    Ciba Found Symp; 1982; 87():120-31. PubMed ID: 6122545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic and hormonal effects of muscular exercise in juvenile type diabetics.
    Berger M; Berchtold P; Cüppers HJ; Drost H; Kley HK; Müller WA; Wiegelmann W; Zimmerman-Telschow H; Gries FA; Krüskemper HL; Zimmermann H
    Diabetologia; 1977 Aug; 13(4):355-65. PubMed ID: 410693
    [No Abstract]   [Full Text] [Related]  

  • 32. Why the diabetic heart is energy inefficient: a ketogenesis and ketolysis perspective.
    Mishra PK
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H751-H755. PubMed ID: 34533402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man.
    Schade DS; Eaton RP
    Diabetes; 1979 Jan; 28(1):5-10. PubMed ID: 759250
    [No Abstract]   [Full Text] [Related]  

  • 34. [Insulin resistance and diabetic ketoacidosis].
    Alberti KG
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():79-90. PubMed ID: 827649
    [No Abstract]   [Full Text] [Related]  

  • 35. Glucagon regulation of plasma ketone body concentration in human diabetes.
    Schade DS; Eaton RP
    J Clin Invest; 1975 Nov; 56(5):1340-4. PubMed ID: 1184755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal control of ketone body metabolism in the normal and diabetic state.
    Johnston DG; Alberti KG
    Clin Endocrinol Metab; 1982 Jul; 11(2):329-61. PubMed ID: 6128093
    [No Abstract]   [Full Text] [Related]  

  • 37. Free fatty acid and ketone body metabolism during exercise in diabetes.
    Wahren J; Hagenfeldt L
    Acta Paediatr Scand Suppl; 1980; 283():39-44. PubMed ID: 6938114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.
    Schade DS; Eaton RP; Peake GT
    Diabetes; 1978 Sep; 27(9):916-24. PubMed ID: 689302
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man.
    Miles JM; Haymond MW; Nissen SL; Gerich JE
    J Clin Invest; 1983 Jun; 71(6):1554-61. PubMed ID: 6134753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon.
    Beylot M
    Diabetes Metab; 1996 Oct; 22(5):299-304. PubMed ID: 8896990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.